IRIS Accounts Production v25.1.4.42 07974307 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079743072024-03-31079743072025-03-31079743072024-04-012025-03-31079743072023-03-31079743072023-04-012024-03-31079743072024-03-3107974307ns15:EnglandWales2024-04-012025-03-3107974307ns14:PoundSterling2024-04-012025-03-3107974307ns10:Director12024-04-012025-03-3107974307ns10:Director22024-04-012025-03-3107974307ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107974307ns10:SmallEntities2024-04-012025-03-3107974307ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107974307ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107974307ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107974307ns10:FullAccounts2024-04-012025-03-310797430712024-04-012025-03-3107974307ns10:RegisteredOffice2024-04-012025-03-3107974307ns5:CurrentFinancialInstruments2025-03-3107974307ns5:CurrentFinancialInstruments2024-03-3107974307ns5:ShareCapital2025-03-3107974307ns5:ShareCapital2024-03-3107974307ns5:RetainedEarningsAccumulatedLosses2025-03-3107974307ns5:RetainedEarningsAccumulatedLosses2024-03-3107974307ns5:NetGoodwill2024-04-012025-03-3107974307ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107974307ns5:PlantMachinery2024-04-012025-03-3107974307ns5:FurnitureFittings2024-04-012025-03-3107974307ns5:ComputerEquipment2024-04-012025-03-3107974307ns5:NetGoodwill2024-03-3107974307ns5:NetGoodwill2025-03-3107974307ns5:NetGoodwill2024-03-3107974307ns5:PlantMachinery2024-03-3107974307ns5:FurnitureFittings2024-03-3107974307ns5:ComputerEquipment2024-03-3107974307ns5:PlantMachinery2025-03-3107974307ns5:FurnitureFittings2025-03-3107974307ns5:ComputerEquipment2025-03-3107974307ns5:PlantMachinery2024-03-3107974307ns5:FurnitureFittings2024-03-3107974307ns5:ComputerEquipment2024-03-3107974307ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107974307ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31
REGISTERED NUMBER: 07974307 (England and Wales)














Financial Statements for the Year Ended 31 March 2025

for

Npsych Clinical Neurosciences Ltd

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Npsych Clinical Neurosciences Ltd

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Dr N H Walton
Dr R J McCarter





REGISTERED OFFICE: The Retreat
406 Roding Lane South
Woodford Green
Essex
IG8 8EY





REGISTERED NUMBER: 07974307 (England and Wales)





ACCOUNTANTS: Nordens
The Retreat
406 Roding Lane South
Woodford Green
Essex
IG8 8EY

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Statement of Financial Position
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Property, plant and equipment 5 17,161 13,949
17,161 13,949

CURRENT ASSETS
Debtors 6 105,150 115,462
Cash at bank and in hand 573,218 481,263
678,368 596,725
CREDITORS
Amounts falling due within one year 7 85,098 108,762
NET CURRENT ASSETS 593,270 487,963
TOTAL ASSETS LESS CURRENT LIABILITIES 610,431 501,912

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 610,331 501,812
SHAREHOLDERS' FUNDS 610,431 501,912

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Statement of Financial Position - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2025 and were signed on its behalf by:




Dr N H Walton - Director



Dr R J McCarter - Director


Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Npsych Clinical Neurosciences Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2012, is being amortised evenly over its estimated useful life of ten years.

The directors have reviewed the value of goodwill and its remaining life and believe that the amounts shown in the financial statements for goodwill and goodwill amortisation are fairly stated.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Computer equipment - 25% on reducing balance

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 800,000
AMORTISATION
At 1 April 2024
and 31 March 2025 800,000
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 -

5. PROPERTY, PLANT AND EQUIPMENT
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2024 16,325 10,312 43,530 70,167
Additions - - 8,747 8,747
Disposals (582 ) - - (582 )
At 31 March 2025 15,743 10,312 52,277 78,332
DEPRECIATION
At 1 April 2024 14,198 9,725 32,295 56,218
Charge for year 231 88 4,996 5,315
Eliminated on disposal (362 ) - - (362 )
At 31 March 2025 14,067 9,813 37,291 61,171
NET BOOK VALUE
At 31 March 2025 1,676 499 14,986 17,161
At 31 March 2024 2,127 587 11,235 13,949

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 100,075 110,755
Other debtors 5,075 4,707
105,150 115,462

Npsych Clinical Neurosciences Ltd (Registered number: 07974307)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade creditors 2,464 3,785
Taxation and social security 79,721 101,533
Other creditors 2,913 3,444
85,098 108,762

8. RELATED PARTY DISCLOSURES

The Directors Dr N H Walton and Dr R J McCarter are considered to be the key management personnel.